comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 19:49:32 - browse：656

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Pregnancy ages women, but effects reverse after delivery

hotspot

WSS

Takeaways from AdvaMed, the largest medical devices conference

European regulators recommend Amylyx's ALS drug be rejected

Testing GLP

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Pregnancy ages women, but effects reverse after delivery

Medicare to cover more brain scans related to Alzheimer’s drugs

leisure time

comprehensive

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Adam's Take: Intra

How to save PrEP access — and even expand it

What Kate Middleton's cancer revelation might teach the world

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bernie Sanders bashes nonprofit hospitals over their tax breaks

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medical devices makers are asking for forgiveness, not permission

At least 13 dead in Texas as scorching temps continue

6 surprising facts about sugar

entertainment

Adam's Take: Intra

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Better Therapeutics data on benefit with GLP

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

European regulators recommend Amylyx's ALS drug be rejected

CRISPR technology availability, affordability needs to be expanded

explore

hotspot

focus

hotspot